Use of florfenicol in non-human primates

Journal of Medical Primatology

Volumn 33, Issue 3, 2004, Pages 127-133

  Cook, Anthony L ^a   St Claire, Marisa ^a   Sams, Richard ^b  

^a BIOQUAL INC   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Antibiotics; Florfenicol; Macaques; Nonhuman primates; Pharmacokinetics

Indexed keywords

ANTIINFECTIVE AGENT; CHLORAMPHENICOL; CHLORAMPHENICOL PALMITATE; FLORFENICOL; KETAMINE; LONG ACTING DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; AUTOPSY; BACTERIAL INFECTION; BLOOD SAMPLING; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; MACACA; MALE; MUSCLE TISSUE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; TOXICITY TESTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-BACTERIAL AGENTS; CHLORAMPHENICOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; FEMALE; HISTOLOGICAL TECHNIQUES; INJECTIONS, INTRAMUSCULAR; MACACA; MALE; MUSCLE, SKELETAL; THIAMPHENICOL; TISSUE DISTRIBUTION;

ANIMALIA; BACTERIA (MICROORGANISMS); BORDETELLA BRONCHISEPTICA; BOS TAURUS; ESCHERICHIA COLI; KLEBSIELLA; MACACA; MACACA MULATTA; PRIMATES; SALMONELLA; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS;

EID: 2442611030     PISSN: 00472565     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2004.00063.x     Document Type: Article

References (21)

1. Afifi NA, el-Sooud KA: Tissue concentration and pharmacokinetics of florfenicol in broiler chickens. DTW Dtsch Tierarztl Wochenschar 104:178-180, 1997.
2. Afifi NA, Aboel-Sooud KA: Tissue concentrations and pharmacokinetics of florfenicol in broiler chickens. Br Poult Sci 38:425-428, 1997.
3. Ayling RD, Baker SE, Nicholas RA, Peek ML, Simon AJ: Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against Mycoplasma mycoides subspecies mycoides small colony type. Vet Rec 146:243-246, 2000.
4. Booker CW, Jim GK, Guichon PT, Schunicht OC, Thorlakson BE, Lockwood PW: Evaluation of florfenicol for the treatment of undifferentiated fever in feedlot calves in western Canada. Can Vet J 38:555-560, 1997.
5. Cannon M, Harford S, Davies J: A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. J Antimicrob Chemother 26:307-317, 1990.
6. de Craene BA, Deprez P, D'Haese E, Nelis HJ, Van den Bossche W, De Leenheer P: Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves. Antimicrob Agents Chemother 41:1991-1995, 1997.
7. Dreassi E, Corbini G, Ginanneschi V, Corti P, Furlanetto S: Planar chromatography and liquid chromatographic analysis of thiamphenicol in bovine and human plasma. J AOAC Int 80:746-750, 1997.
8. Gibson SV: Bacterial and mycotic diseases. In: Nonhuman Primates in Biomedical Research Diseases Bennett, Abee & Henrickson (eds). San Diego, CA: Academic Press, Inc. 59-102, 1998.
9. Hawk CT, Leary SL: Formulary for Laboratory Animals. Ames, IA: Iowa State University Press, 1995.
10. Kim E, Aoki T: Sequence analysis of the florfenicol resistance gene encoded in the transferrable R-plasmid of a fish pathogen, pasteurella piscicida. Microbiol Immunol 40:665-669, 1996.
11. Lavy E, Ziv G, Sorback S, Glickman A, Winkler M: Clinical pharmacology of florfenicol in lactating goats. Acta Vet Scand Suppl 87:133-136, 1991.
12. Lobell RD, Varma KJ, Johnson JC, Sams RA, Gerken DF, Ashcraft SM: Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J Vet Pharmacol Ther 17:253-258, 1994.
13. Marshall SA, Jones RN, Wagner A, Washington JA, Doern GV, Leber AL, Haugen TH: Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin, G-novobiocin, pirlimycin, premafloxacin, and spectinomycin. J Clin Microbiol 34:2027-2029, 1996.
14. Paape MJ, Miller RH, Ziv G: Effects of florfenicol, chloramphenicol, and thiamphenicol on phagocytosis. J Dairy Sci 73:173-244, 1990.
15. Parker RF, Davis JK, Cassell GH, White H, Dziedzic D, Blalock DK, Thorp RB, Simecka JW: Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis. Am Rev Respir Dis 140:502-512, 1989.
16. Plumb A, Donald C: Veterinary Drug Handbook, 3rd edn. White Bear Lake, MN: Pharmavet Publ 281-282, 1999.
17. Schering-Plough: Nuflor Chemistry, Antimicrobial Activity and Pharmacokinetics. Kenilworth, NJ: Schering-Plough, 1996.
18. Soback S, Paape MJ, Filiep R, Varma KJ: Florfenicol pharmacokinetics in lactating cows after intravenous, intramuscular and intramammary administration. J Vet Pharmacol Therap 18:413-417, 1995.
19. Ueda Y, Ohtsuki S: Efficacy of florfenicol on experimental Actinobacillus pleuropneumonia in pigs. J Vet Med Sci 57:261-265, 1995.
20. Varma KJ, Sams RA, Lobell RD, Lockwood PW: Pharmacokinetics and efficacy of a new broad spectrum antibiotic: florfenicol in cattle. Acta Vet Scand Suppl 87:102-104, 1991.
21. Wolson DJ, Sears PM, Gonzales RN, Smith BS, Schulte HF, III, Bennett GJ, Das HH, Johnson CK: Efficacy of florfenicol for treatment of clinical and subclinical bovine mastitis. Am J Vet Res 57:562-568, 1996.